Definium Therapeutics Inc (DFTX) returns
Definium Therapeutics returns over 3 years
$1,000 invested in Definium Therapeutics three years ago was worth $14,081 at the close on October 30, 2026, with dividends reinvested: an average return of 141.5% a year. The same $1,000 in the S&P 500 (SPY) became $1,885.
Total return by period
| Period | Total return | A year, on average | $1,000 became | S&P 500 (SPY) |
|---|---|---|---|---|
| 1 month | -4.5% | — | $954.55 | -0.9% |
| 3 months | -18.3% | — | $816.59 | +2.1% |
| Year to date | +171.3% | — | $2,713 | +11.7% |
| 1 year | +171.3% | — | $2,713 | +12.4% |
| 3 years | +1,308% | +141.5% | $14,081 | +88.5% |
Definium Therapeutics return by calendar year
| Year | DFTX | S&P 500 (SPY) | Difference |
|---|---|---|---|
| 2026 to date | +171.3% | +11.7% | +159.6% |
| 2025 | +92.4% | +17.7% | +74.7% |
| 2024 | +90.2% | +24.9% | +65.3% |
| 2023 | +66.4% | +26.2% | +40.2% |
Past returns do not predict future returns. Returns are computed from our daily closes, adjusted for splits and with dividends reinvested on their ex-dates; taxes and trading costs are left out.
See also:
No forecast, no recommendation. This page describes Definium Therapeutics Inc from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.